• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防性甲状腺切除术在多发性内分泌腺瘤 2 型(MEN2)患者 C634Y 突变中的应用:一项大型单中心队列的长期随访研究。

Prophylactic thyroidectomy in multiple endocrine neoplasia 2 (MEN2) patients with the C634Y mutation: A long-term follow-up in a large single-center cohort.

机构信息

General Surgery Service, Endocrine Surgery Unit, Instituto Murciano de Investigaciones Biomédicas (IMIB), Virgen de la Arrixaca University Hospital, Murcia, CP 30120, Spain.

General Surgery Service, Endocrine Surgery Unit, Instituto Murciano de Investigaciones Biomédicas (IMIB), Virgen de la Arrixaca University Hospital, Murcia, CP 30120, Spain.

出版信息

Eur J Surg Oncol. 2019 Apr;45(4):625-630. doi: 10.1016/j.ejso.2018.09.002. Epub 2018 Oct 17.

DOI:10.1016/j.ejso.2018.09.002
PMID:30366876
Abstract

BACKGROUND

Medullary thyroid carcinoma (MTC) is the main cause of death in multiple endocrine neoplasia 2A (MEN2A) patients. It is therefore important to treat this disease at an early stage. The mutation in codon 634 is considered to be associated with an aggressive clinical course, whereas the C634Y mutation may result in a more indolent course. Prophylactic thyroidectomy is performed before thyroid disease occurs. However, controversy surrounds this disease regarding levels of calcitonin (Ct) and age. In this context, few studies have investigated this mutation over a long period.

OBJECTIVE

To analyze a large cohort of patients with the C634Y mutation who received prophylactic thyroidectomy.

MATERIALS AND METHODS

In a group of 110 MEN2 patients, we analyzed those with the C634Y mutation who had received prophylactic thyroidectomy (absence of clinical and radiological thyroid disease) treated in a tertiary referral hospital between 1983 and 2016. MTC is related to age and Ct. Statistical analysis was performed using the χ test, partial correlations, and logistic regression.

RESULTS

Fifty patients with a mean age of 12 ± 9 years were analyzed; 56% of these had MTC (100% stage I). There was no case of hypoparathyroidism or permanent recurrent damage. MTC was associated mainly with age (OR 1.38). One 5-year-old patient presented with MTC. Mean follow-up time was 16 ± 6 years, and no cases of recurrence were observed.

CONCLUSIONS

Performing prophylactic thyroidectomy in patients with the C634Y mutation allows us to cure the disease without causing long-term complications. Our results support the notion that age <5 years should be a criterion for carrying out prophylactic thyroidectomy in these patients.

摘要

背景

甲状腺髓样癌(MTC)是多发性内分泌肿瘤 2A(MEN2A)患者死亡的主要原因。因此,早期治疗这种疾病非常重要。密码子 634 的突变被认为与侵袭性临床病程相关,而 C634Y 突变可能导致更惰性的病程。预防性甲状腺切除术在甲状腺疾病发生之前进行。然而,关于降钙素(Ct)和年龄水平,对此病存在争议。在这种情况下,很少有研究在很长一段时间内对这种突变进行了调查。

目的

分析接受预防性甲状腺切除术的 C634Y 突变大型患者队列。

材料和方法

在一组 110 名 MEN2 患者中,我们分析了在三级转诊医院于 1983 年至 2016 年间接受预防性甲状腺切除术(无临床和放射学甲状腺疾病)的 C634Y 突变患者。MTC 与年龄和 Ct 有关。使用 χ 检验、偏相关和逻辑回归进行统计分析。

结果

分析了 50 名平均年龄为 12±9 岁的患者;其中 56%患有 MTC(100%为 I 期)。没有发生甲状旁腺功能减退症或永久性复发损伤。MTC 主要与年龄相关(OR 1.38)。一名 5 岁患者患有 MTC。平均随访时间为 16±6 年,未观察到复发病例。

结论

对 C634Y 突变患者进行预防性甲状腺切除术可以治愈疾病,而不会引起长期并发症。我们的结果支持这样的观点,即年龄<5 岁应该是对这些患者进行预防性甲状腺切除术的标准。

相似文献

1
Prophylactic thyroidectomy in multiple endocrine neoplasia 2 (MEN2) patients with the C634Y mutation: A long-term follow-up in a large single-center cohort.预防性甲状腺切除术在多发性内分泌腺瘤 2 型(MEN2)患者 C634Y 突变中的应用:一项大型单中心队列的长期随访研究。
Eur J Surg Oncol. 2019 Apr;45(4):625-630. doi: 10.1016/j.ejso.2018.09.002. Epub 2018 Oct 17.
2
A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.挪威2A型多发性内分泌腺瘤病的全国性研究:甲状腺髓样癌临床病程的预测和预后因素
Thyroid. 2016 Sep;26(9):1225-38. doi: 10.1089/thy.2015.0673. Epub 2016 Aug 11.
3
Prophylactic thyroidectomies in MEN2 syndrome: Management and outcomes.MEN2综合征中的预防性甲状腺切除术:管理与结果
J Pediatr Surg. 2018 Feb;53(2):283-285. doi: 10.1016/j.jpedsurg.2017.11.015. Epub 2017 Nov 13.
4
Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.遗传性甲状腺髓样癌的基因型-表型相关性
Recent Results Cancer Res. 2015;204:139-56. doi: 10.1007/978-3-319-22542-5_6.
5
Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.2A和2B型多发性内分泌腺瘤病患儿的甲状腺髓样癌
J Pediatr Surg. 1996 Jan;31(1):177-81; discussion 181-2. doi: 10.1016/s0022-3468(96)90343-7.
6
Present status of prophylactic thyroidectomy in pediatric multiple endocrine neoplasia 2: a nationwide survey in Japan 1997-2017.儿童多发性内分泌腺瘤病2型预防性甲状腺切除术的现状:1997 - 2017年日本全国性调查
J Pediatr Endocrinol Metab. 2019 Jun 26;32(6):585-595. doi: 10.1515/jpem-2018-0444.
7
Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China.基于中国 RET 原癌基因突变和基础降钙素检测对 MEN2 相关甲状腺髓样癌的预防性甲状腺切除术。
Eur J Surg Oncol. 2013 Sep;39(9):1007-12. doi: 10.1016/j.ejso.2013.06.015. Epub 2013 Jul 9.
8
Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.2A 型多发性内分泌腺瘤病家系中 RET 密码子 804 突变患者预防性甲状腺切除术的经验。
Clin Endocrinol (Oxf). 2005 Dec;63(6):636-41. doi: 10.1111/j.1365-2265.2005.02394.x.
9
Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.遗传性甲状腺髓样癌的早期预防性甲状腺切除术:一项长达26年的单机构经验
Am J Clin Oncol. 2015 Oct;38(5):508-13. doi: 10.1097/COC.0b013e3182a78fec.
10
Prophylactic thyroidectomy in ethnic Chinese patients with multiple endocrine neoplasia type 2A syndrome after the introduction of genetic testing.基因检测引入后,中国汉族2A型多发性内分泌腺瘤综合征患者的预防性甲状腺切除术
Hong Kong Med J. 2009 Oct;15(5):326-31.

引用本文的文献

1
Kinome profiling reveals pathogenic variant specific protein signalling networks in MEN2 children with Medullary Thyroid Cancer.激酶组分析揭示了患有甲状腺髓样癌的MEN2儿童中特定致病变体的蛋白质信号网络。
NPJ Precis Oncol. 2025 May 2;9(1):125. doi: 10.1038/s41698-025-00919-4.
2
An Analysis of Primary Hyperparathyroidism in Individuals Diagnosed with Multiple Endocrine Neoplasia Type 2.对诊断为2型多发性内分泌腺瘤病的个体的原发性甲状旁腺功能亢进症的分析。
Diseases. 2025 Mar 27;13(4):98. doi: 10.3390/diseases13040098.
3
Histopathology of C Cells and Medullary Thyroid Carcinoma.
C细胞与甲状腺髓样癌的组织病理学
Recent Results Cancer Res. 2025;223:9-50. doi: 10.1007/978-3-031-80396-3_2.
4
mutation in -induced multiple endocrine neoplasia type 2A: A case report.突变诱导的2A型多发性内分泌腺瘤病:一例报告。
World J Clin Cases. 2024 May 26;12(15):2627-2635. doi: 10.12998/wjcc.v12.i15.2627.
5
A case report of multiple endocrine neoplasia type 2B.2B型多发性内分泌腺瘤病病例报告
Ann Med Surg (Lond). 2024 Apr 3;86(5):3016-3019. doi: 10.1097/MS9.0000000000001867. eCollection 2024 May.
6
Serum Biochemical Markers for Medullary Thyroid Carcinoma: An Update.甲状腺髓样癌的血清生化标志物:最新进展
Cancer Manag Res. 2024 Apr 8;16:299-310. doi: 10.2147/CMAR.S440477. eCollection 2024.
7
RET Proto-Oncogene Variants in Patients with Medullary Thyroid Carcinoma from the Mediterranean Basin: A Brief Report.地中海地区甲状腺髓样癌患者的RET原癌基因变异:简要报告
Life (Basel). 2023 Jun 6;13(6):1332. doi: 10.3390/life13061332.
8
Germline Pathogenic Variants Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma.通过对嗜铬细胞瘤和副神经节瘤易感基因进行靶向二代测序鉴定出的胚系致病变异
J Kidney Cancer VHL. 2021 Mar 13;8(1):19-24. doi: 10.15586/jkcvhl.v8i1.171. eCollection 2021.